Advertisement

Topics

Adaptive Biotechnologies Company Profile

11:59 EST 18th December 2018 | BioPortfolio

Adaptive Biotechnologies is the pioneer and leader in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. Adaptive is bringing the accuracy and sensitivity of its immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases. Adaptive also translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care.


News Articles [243 Associated News Articles listed on BioPortfolio]

Adaptive Biotechnologies gets FDA approval for clonoSEQ assay

The clonoSEQ assay, which uses DNA from a patient’s bone marrow sample, deploys next-generation sequencing (NGS) technology to evaluate disease burden. The clonoSEQ is the first and only The post A...

FDA grants de novo designation to Adaptive's clonoSEQ assay

The FDA has granted de novo designation to Adaptive Biotechnologies' clonoSEQ assay for minimal residual disease in patients  -More- 

DGAP-Stimmrechte: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: Elanix Biotechnologies AG Elanix Biotechnologies AG: Veröf...

Study Shows that Measuring MRD Negativity Using Adaptive’s Next-Generation Sequencing Platform is a Major Predictive Indicator in Multiple Myeloma

SEATTLE–(BUSINESS WIRE)–Adaptive Biotechnologies today announced that Blood, the Journal of the American Society of Hematology (ASH), published online an analysis of patient samples from ...

FDA Authorizes Adaptive’s clonoSEQ Assay to Detect MRD in Patients with Multiple Myeloma and Acute Lymphoblastic Leukemia

SEATTLE–(BUSINESS WIRE)–Adaptive Biotechnologies® announced today that the U.S. Food and Drug Administration (FDA) has granted De Novo designation for the clonoSEQ® Assay to detect and...

FDA approves first NGS test to detect minimal residual disease in two blood cancers

In a first, the agency approved Adaptive Biotechnologies’ clonoSEQ assay to detect MRD in acute lymphoblastic

DGAP-Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG / Ve.....

Deals this week: SQZ Biotechnologies, Immugenyx, Berkeley Lights

SQZ Biotechnologies has expanded its collaboration with Roche to develop products for oncology indications using cellular therapy. The two companies...Read More... The post Deals this week: SQZ Biotec...

Drugs and Medications [0 Results]

None

PubMed Articles [458 Associated PubMed Articles listed on BioPortfolio]

Adaptive ensemble simulations of biomolecules.

Recent advances in both theory and computational power have created opportunities to simulate biomolecular processes more efficiently using adaptive ensemble simulations. Ensemble simulations are now ...

Dynamics of an intraguild predation model with an adaptive IGpredator.

In this paper, an intraguild predation model with an adaptive IGpredator is studied. IGpredator is assumed to adopt adaptive predation strategy to gain more fitness and the adaptive strength is variab...

Gut Immunity: Passing on the Baton from Innate to Adaptive Immunity.

Innate and adaptive immunity are two complementary systems that work together to protect the host organism. A new study unravels how innate lymphoid cells and adaptive T lymphocytes act sequentially t...

Evaluation of resource burden for bladder adaptive strategies: A timing study.

Interfraction bladder motion is substantial and therefore many different adaptive radiotherapy approaches have been developed to accommodate that motion. Previous studies comparing the efficacy of tho...

The Bayesian adaptive lasso regression.

Classical adaptive lasso regression is known to possess the oracle properties; namely, it performs as well as if the correct submodel were known in advance. However, it requires consistent initial est...

Clinical Trials [529 Associated Clinical Trials listed on BioPortfolio]

Shrinking Target Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer

This study aims to use a type of radiation (adaptive radiotherapy) to deliver curative-intent treatment to patients with non-small cell lung cancer, whose tumors would otherwise be too lar...

Adaptive Cardiac Resynchronization Therapy Study

The purpose of this study is to show that Adaptive CRT is at least as good at optimizing a patient's cardiac resynchronization therapy (CRT) as the current method of using an echocardiogra...

Adaptive Behaviors Among Women With Bowel Incontinence: The ABBI Trial

This study focuses on the validation of the Adaptation Index instrument as a measurement of adaptive behaviors used to reduce symptoms of FI and to describe the use of adaptive behaviors a...

The Clinical Physics Research of Image Guided Adaptive Radiation Therapy for Esophagus Cancer

The purpose of this study is to evaluate the benefit of adaptive radiation therapy (adaptive radiation therapy, ART) for esophageal cancer, using dose tracking technique with online images...

Double-Blind Randomized Controlled Trial for the Evaluation of a Novel Adaptive Attention Training in Healthy Adolescents

This project will evaluate the neuro-cognitive outcomes of a novel, adaptive attention training in a healthy adolescent population.

Companies [168 Associated Companies listed on BioPortfolio]

Adaptive Biotechnologies

Adaptive Biotechnologies is the pioneer and leader in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. Adaptive is bringing t...

Multiple Myeloma Research Foundation and Adaptive Biotechnologies

Adaptive Biotechnologies Corporation is a platform-based, diagnostic-driven company that leverages NGS to profile T-Cell and B-Cell Receptors. This breakthrough enables in-depth c...

Adaptive Corporation

Adaptive Corporation is a leading provider of Business Process Automation and Product Development technology and services. The company helps its customers become market leaders th...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

More Information about "Adaptive Biotechnologies" on BioPortfolio

We have published hundreds of Adaptive Biotechnologies news stories on BioPortfolio along with dozens of Adaptive Biotechnologies Clinical Trials and PubMed Articles about Adaptive Biotechnologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Adaptive Biotechnologies Companies in our database. You can also find out about relevant Adaptive Biotechnologies Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record